Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update - November 2012

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update for November 2012 (PDF).

This update contains hot topic information advising clinicians that when reporting suspected adverse drug reactions to biological medicines, such as biosimilar products or vaccines, it is important to include the brand name and if possible the batch number. Products in this category may not be identical and reporting may also help to identify concerns related to specific batches.

This section also contains the findings of a safety review of the HPV vaccine Cervarix® which confirmed that the "balance of its risks and benefits remains clearly positive".

Finally, this issue contains a link to a new learning module for antipsychotics. This module is accredited for up to 3.5 CPD credits.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update - November 2012' on Email Share 'Drug Safety Update - November 2012' on Delicious Share 'Drug Safety Update - November 2012' on Digg Share 'Drug Safety Update - November 2012' on Facebook Share 'Drug Safety Update - November 2012' on Google+ Share 'Drug Safety Update - November 2012' on reddit Share 'Drug Safety Update - November 2012' on StumbleUpon Share 'Drug Safety Update - November 2012' on Twitter

atomic-wealth

No Comments to “Drug Safety Update - November 2012”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,217 spam comments.

atomic-wealth
fond-illness
summer